메뉴 건너뛰기




Volumn 89, Issue 1, 2008, Pages 44-50

A phase II trial of low-dose gemcitabine and radiation alternated to cisplatin and 5-fluorouracil: An active and manageable regimen for stage IV squamous cell carcinoma of the head and neck

Author keywords

Chemo radiotherapy; Gemcitabine; Head and neck

Indexed keywords

CISPLATIN; FLUOROURACIL; GEMCITABINE;

EID: 53049086833     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.04.002     Document Type: Article
Times cited : (8)

References (26)
  • 2
    • 0345714860 scopus 로고    scopus 로고
    • Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer
    • Forastiere A., Goepfert H., Maor M., et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349 (2003) 2091-2098
    • (2003) N Engl J Med , vol.349 , pp. 2091-2098
    • Forastiere, A.1    Goepfert, H.2    Maor, M.3
  • 3
    • 53049101141 scopus 로고    scopus 로고
    • Forastiere A, Maor M, Weber RS et al. Long-term results of Intergroup RTOG 91-11: a phase III trial to preserve the larynx. Induction cisplatin/5-FU and radiation therapy versus concurrent cisplatin and radiation therapy versus radiation therapy. In: Proc. ASCO 2006, abs no 5517.
    • Forastiere A, Maor M, Weber RS et al. Long-term results of Intergroup RTOG 91-11: a phase III trial to preserve the larynx. Induction cisplatin/5-FU and radiation therapy versus concurrent cisplatin and radiation therapy versus radiation therapy. In: Proc. ASCO 2006, abs no 5517.
  • 4
    • 0034681783 scopus 로고    scopus 로고
    • Chemotherapy added to loco-regional treatment for head and neck squamous cell carcinoma: three meta-analyses of updated individual data
    • Pignon J.P., Bourhis J., Domenge C., et al. Chemotherapy added to loco-regional treatment for head and neck squamous cell carcinoma: three meta-analyses of updated individual data. Lancet 355 (2000) 949-955
    • (2000) Lancet , vol.355 , pp. 949-955
    • Pignon, J.P.1    Bourhis, J.2    Domenge, C.3
  • 5
    • 34548428839 scopus 로고    scopus 로고
    • Meta-analyses of chemotherapy in head and neck cancer (MACH-NC): an update
    • Pignon J.P., le Mai{dotless}̂tre A., Bourhis J., et al. Meta-analyses of chemotherapy in head and neck cancer (MACH-NC): an update. Int J Radiat Oncol Biol Phys 69 (2007) 112-114
    • (2007) Int J Radiat Oncol Biol Phys , vol.69 , pp. 112-114
    • Pignon, J.P.1    le Maître, A.2    Bourhis, J.3
  • 6
    • 0026779826 scopus 로고
    • Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy
    • Merlano M., Vitale V., Rosso R., et al. Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N Engl J Med 327 (1992) 1115-1121
    • (1992) N Engl J Med , vol.327 , pp. 1115-1121
    • Merlano, M.1    Vitale, V.2    Rosso, R.3
  • 7
    • 9244264477 scopus 로고    scopus 로고
    • Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck
    • Merlano M., Benasso M., Corvò R., et al. Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck. J Natl Cancer Inst 88 (1996) 583-589
    • (1996) J Natl Cancer Inst , vol.88 , pp. 583-589
    • Merlano, M.1    Benasso, M.2    Corvò, R.3
  • 8
    • 0035575766 scopus 로고    scopus 로고
    • Alternating chemoradiotherapy versus partly accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck
    • Corvò R., Benasso M., Sanguineti G., et al. Alternating chemoradiotherapy versus partly accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck. Cancer 92 (2001) 2856-2867
    • (2001) Cancer , vol.92 , pp. 2856-2867
    • Corvò, R.1    Benasso, M.2    Sanguineti, G.3
  • 9
    • 53049091219 scopus 로고    scopus 로고
    • Lefebvre J, Horiot J, Rolland F et al. Phase III study on larynx preservation comparing induction chemotherapy and radiotherapy versus alternating chemoradiotherapy in resectable hypopharynx and larynx cancers: EORTC protocol 24954-22950. In: Proceed. ASCO 2007, abs no LBA6016.
    • Lefebvre J, Horiot J, Rolland F et al. Phase III study on larynx preservation comparing induction chemotherapy and radiotherapy versus alternating chemoradiotherapy in resectable hypopharynx and larynx cancers: EORTC protocol 24954-22950. In: Proceed. ASCO 2007, abs no LBA6016.
  • 10
    • 0028784506 scopus 로고
    • Interaction between cisplatin and gemcitabine in vitro and in vivo
    • Peters G.J., Bergman A.M., Ruiz van Haperen V.W.T., et al. Interaction between cisplatin and gemcitabine in vitro and in vivo. Semin Oncol 22 (1995) 72-79
    • (1995) Semin Oncol , vol.22 , pp. 72-79
    • Peters, G.J.1    Bergman, A.M.2    Ruiz van Haperen, V.W.T.3
  • 11
    • 0032441793 scopus 로고    scopus 로고
    • Phase II trial of cisplatin and gemcitabine in advanced squamous-cell carcinoma of the head and neck
    • Hitt R., Castellano D., Hidalgo M., et al. Phase II trial of cisplatin and gemcitabine in advanced squamous-cell carcinoma of the head and neck. Ann Oncol 9 (1998) 1347-1349
    • (1998) Ann Oncol , vol.9 , pp. 1347-1349
    • Hitt, R.1    Castellano, D.2    Hidalgo, M.3
  • 12
    • 0029805849 scopus 로고    scopus 로고
    • Gemcitabine and radiosensitization in human tumor cells
    • Shewach D.S., and Lawrence T.S. Gemcitabine and radiosensitization in human tumor cells. Invest New Drugs 14 (1996) 257-263
    • (1996) Invest New Drugs , vol.14 , pp. 257-263
    • Shewach, D.S.1    Lawrence, T.S.2
  • 13
    • 0035253713 scopus 로고    scopus 로고
    • Radiation concurrent with gemcitabine for locally advanced head and neck cancer: a phase I trial and intracellular drug incorporation study
    • Eisbruch A., Shewach D.S., Bradford C.R., et al. Radiation concurrent with gemcitabine for locally advanced head and neck cancer: a phase I trial and intracellular drug incorporation study. J Clin Oncol 19 (2001) 792-799
    • (2001) J Clin Oncol , vol.19 , pp. 792-799
    • Eisbruch, A.1    Shewach, D.S.2    Bradford, C.R.3
  • 14
    • 0035205773 scopus 로고    scopus 로고
    • Gemcitabine, cisplatin, and radiation for advanced, unresectable squamous cell carcinoma of the head and neck. A feasibility study
    • Benasso M., Merlano M., Sanguineti G., et al. Gemcitabine, cisplatin, and radiation for advanced, unresectable squamous cell carcinoma of the head and neck. A feasibility study. Am J Clin Oncol 24 (2001) 618-622
    • (2001) Am J Clin Oncol , vol.24 , pp. 618-622
    • Benasso, M.1    Merlano, M.2    Sanguineti, G.3
  • 15
    • 2342438685 scopus 로고    scopus 로고
    • Alternating gemcitabine and cisplatin with gemcitabine and radiation in stage IV squamous cell carcinoma of the head and neck
    • Benasso M., Corvò R., Ponzanelli A., et al. Alternating gemcitabine and cisplatin with gemcitabine and radiation in stage IV squamous cell carcinoma of the head and neck. Ann Oncol 15 (2004) 646-652
    • (2004) Ann Oncol , vol.15 , pp. 646-652
    • Benasso, M.1    Corvò, R.2    Ponzanelli, A.3
  • 16
    • 0034861302 scopus 로고    scopus 로고
    • Evaluation of gemcitabine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
    • Samlowski W.E., Gundacker H., Kuebler J.P., et al. Evaluation of gemcitabine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. Invest New Drugs 19 (2001) 311-315
    • (2001) Invest New Drugs , vol.19 , pp. 311-315
    • Samlowski, W.E.1    Gundacker, H.2    Kuebler, J.P.3
  • 17
    • 0019365237 scopus 로고
    • Reporting results of cancer treatment
    • Miller A.B., Hoogstraten B., Staquet M., et al. Reporting results of cancer treatment. Cancer 47 (1981) 207-214
    • (1981) Cancer , vol.47 , pp. 207-214
    • Miller, A.B.1    Hoogstraten, B.2    Staquet, M.3
  • 19
    • 0020108590 scopus 로고
    • One-sample multiple testing procedure for phase II clinical trial
    • Fleming T.R. One-sample multiple testing procedure for phase II clinical trial. Biometrics 38 (1982) 143-151
    • (1982) Biometrics , vol.38 , pp. 143-151
    • Fleming, T.R.1
  • 20
    • 33845382806 scopus 로고
    • Non-parametric estimation for incomplete observation
    • Kaplan E.L., and Meyer P. Non-parametric estimation for incomplete observation. J Am Stat Assoc 53 (1958) 457-474
    • (1958) J Am Stat Assoc , vol.53 , pp. 457-474
    • Kaplan, E.L.1    Meyer, P.2
  • 21
    • 0029076576 scopus 로고
    • Overview of late effects normal tissues (LENT) scoring system
    • Rubin P., Constine L.S., Fajardo L.F., et al. Overview of late effects normal tissues (LENT) scoring system. Radiotherapy & Oncology 35 (1995) 9-10
    • (1995) Radiotherapy & Oncology , vol.35 , pp. 9-10
    • Rubin, P.1    Constine, L.S.2    Fajardo, L.F.3
  • 22
    • 21144448598 scopus 로고    scopus 로고
    • concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: Radiation Therapy Oncology Group phase II trial 99-14
    • Ang K.K., Harris J., Garden A.S., et al. concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: Radiation Therapy Oncology Group phase II trial 99-14. J Clin Oncol 23 (2005) 3008-3015
    • (2005) J Clin Oncol , vol.23 , pp. 3008-3015
    • Ang, K.K.1    Harris, J.2    Garden, A.S.3
  • 23
    • 33748636873 scopus 로고    scopus 로고
    • Phase I/II study of docetaxel, cisplatin, and concomitant boost radiation for locally advanced squamous cell carcinoma of the head and neck
    • Tsao A.S., Garden A.S., Kies M.S., et al. Phase I/II study of docetaxel, cisplatin, and concomitant boost radiation for locally advanced squamous cell carcinoma of the head and neck. J Clin Oncol 24 (2006) 4163-4169
    • (2006) J Clin Oncol , vol.24 , pp. 4163-4169
    • Tsao, A.S.1    Garden, A.S.2    Kies, M.S.3
  • 24
    • 33748949062 scopus 로고    scopus 로고
    • Gemcitabine and cisplatin in a concomitant alternating chemoradiotherapy program for locally advanced head-and-neck cancer: a pharmacology-guided schedule
    • Numico G., Russi E.G., Vitiello R., et al. Gemcitabine and cisplatin in a concomitant alternating chemoradiotherapy program for locally advanced head-and-neck cancer: a pharmacology-guided schedule. Int J Radiat Oncol Biol Phys 66 (2006) 731-737
    • (2006) Int J Radiat Oncol Biol Phys , vol.66 , pp. 731-737
    • Numico, G.1    Russi, E.G.2    Vitiello, R.3
  • 25
    • 10744224541 scopus 로고    scopus 로고
    • Phase II trial of gemcitabine concurrent with radiation for locally advanced squamous cell carcinoma of the head and neck
    • Aguilar-Ponce J., Granados-Garcia M., Villavicencio V., et al. Phase II trial of gemcitabine concurrent with radiation for locally advanced squamous cell carcinoma of the head and neck. Ann Oncol 15 (2004) 301-306
    • (2004) Ann Oncol , vol.15 , pp. 301-306
    • Aguilar-Ponce, J.1    Granados-Garcia, M.2    Villavicencio, V.3
  • 26
    • 1642382955 scopus 로고    scopus 로고
    • Competing causes of death and second primary tumor in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy
    • Argiris A., Brockstein B.E., Haraf D.J., et al. Competing causes of death and second primary tumor in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy. Clin Cancer Res 10 (2004) 1956-1962
    • (2004) Clin Cancer Res , vol.10 , pp. 1956-1962
    • Argiris, A.1    Brockstein, B.E.2    Haraf, D.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.